Previous close | 1.8200 |
Open | 1.8100 |
Bid | 1.8200 x 600 |
Ask | 1.8500 x 800 |
Day's range | 1.4300 - 1.8400 |
52-week range | 0.5000 - 3.9300 |
Volume | |
Avg. volume | 2,184,175 |
Market cap | 279.069M |
Beta (5Y monthly) | 1.80 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We feel now is a pretty good time to analyse Heron Therapeutics, Inc.'s ( NASDAQ:HRTX ) business as it appears the...
Over the last 7 days, the market has dropped 4.4%, yet in the last year, it is up 19%, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks that align with these trends can be crucial for investors seeking robust opportunities in the United States market.
Heron Therapeutics ( NASDAQ:HRTX ) Second Quarter 2024 Results Key Financial Results Revenue: US$36.0m (up 13% from 2Q...